JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408238200 on October 13, 2004

J. Biol. Chem., Vol. 279, Issue 53, 55578-55586, December 31, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/53/55578    most recent
M408238200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakata, S.
Right arrow Articles by Kanakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakata, S.
Right arrow Articles by Kanakura, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

NF-{kappa}B Family Proteins Participate in Multiple Steps of Hematopoiesis through Elimination of Reactive Oxygen Species*

Soichi Nakata{ddagger}, Itaru Matsumura{ddagger}§, Hirokazu Tanaka{ddagger}, Sachiko Ezoe{ddagger}, Yusuke Satoh{ddagger}, Jun Ishikawa{ddagger}, Takumi Era¶, and Yuzuru Kanakura{ddagger}

From the {ddagger}Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka 565-0871, Japan and theStem Cell Biology Group, RIKEN Center for Development Biology, 2-2-3, Minatojima-minami-machi, Tyuo-ku, Kobe City, Hyogo 650-0047, Japan

To examine the roles for NF-{kappa}B family proteins in hematopoiesis, we first expressed dominant negative Rel/NF-{kappa}B(I{kappa}BSR) in a factor-dependent cell line, Ba/F3. Although I{kappa}BSR neither affected thrombopoietin-dependent nor gp130-mediated growth, it suppressed interleukin-3- and erythropoietin-dependent growth at low concentrations. In addition, I{kappa}BSR enhanced factor-deprived apoptosis through the accumulation of reactive oxygen species (ROS). When expressed in normal hematopoietic stem/progenitor cells, I{kappa}BSR induced apoptosis even in the presence of appropriate cytokines by accumulating ROS. We also expressed I{kappa}BSR in an inducible fashion at various stages of hematopoiesis using the OP9 system, in which hematopoietic cells are induced to develop from embryonic stem cells. When I{kappa}BSR was expressed at the stage of Flk-1+ cells (putative hemangioblasts), I{kappa}BSR inhibited the development of primitive hematopoietic progenitor cells by inducing apoptosis through the ROS accumulation. Furthermore, when I{kappa}BSR was expressed after the development of hematopoietic progenitor cells, it inhibited their terminal differentiation toward erythrocytes, megakaryocytes, and granulocytes by inducing apoptosis through the ROS accumulation. These results indicate that NF-{kappa}B is required for preventing apoptosis at multiple steps of hematopoiesis by eliminating ROS.


Received for publication, July 21, 2004 , and in revised form, September 27, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 81-6-6879-3871; Fax: 81-6-6879-3879; E-mail: matumura{at}bldon.med.osaka-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Erusalimsky and S. Moncada
Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Naujokat and T. Saric
Concise Review: Role and Function of the Ubiquitin-Proteasome System in Mammalian Stem and Progenitor Cells
Stem Cells, October 1, 2007; 25(10): 2408 - 2418.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
D. Cilloni, G. Martinelli, F. Messa, M. Baccarani, and G. Saglio
Nuclear factor {kappa}B as a target for new drug development in myeloid malignancies
Haematologica, September 1, 2007; 92(9): 1224 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells, January 1, 2007; 25(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Um and H. F. Lodish
Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways
J. Biol. Chem., March 3, 2006; 281(9): 5648 - 5656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.